Concentrations of ambient PM2.5 (particulate matter c2.5 pm in aerodynamic diameter) were associated with increased mortality in two prospective cohort studies. In this paper, 1 assess whether the weight of the evidence supports a causal association. I 
htp:/llehpnetI.niebs.nib.gou/ldcs/I9981106p535-549gambke/abstr bthm In 1997, President Clinton approved an EPA recommendation for a fine particulate matter (PM2 5) National Ambient Air Quality Standard (NAAQS) of 15 pg/m3. Particulate matter less than 2.5 pm in aerodynamic diameter has heretofore been regulated indirectly through regulation of PM1O.
Fine particulates are generally derived from high temperature processes such as combustion or metallurgical operations emitting vapors, which tend to condense on fine particulate. Tobacco smoke and atmospheric transformation products of SO2, NO2, and organics (including biogenic organics) are also mostly in the 0.1-1.0 pm aerodynamic diameter range. The chemical composition tends to be sulfates, acids, metal salts, and carbon. The coarse mode is generally derived from resuspension of soil, industrial dusts, construction, coal and oil combustion, and ocean spray. Composition tends to be flyash (coal and oil), metal oxides, CaCO3, NaCl (sea salt), pollen, mold spores, and plant parts (1) . The new standard for PM25 was recommended because of the hypothesis that fine particles "are a better surrogate for those particle components linked to mortality and morbidity effects at levels below the current [PM10] standards" (2) .
To establish the annual PM2.5 NAAQS, the EPA placed great emphasis on two prospective cohort mortality studies: the Six Cities cohort (3) and the American Cancer Society (ACS) cohort (4 1983 .
Study results are presented as the risk of mortality (e.g., total, cardiopulmonary) associated with the difference in PM2.5
annual concentration between the highest and lowest polluted cities. For example, in the Six Cities study, a 26% increased risk of mortality [relative risk (RR) = 1.26) is associated with an exposure difference of 18.6 pg/m3 PM2.5 (the difference in annual PM2.5 between Steubenville, OH and Portage, WI). The results from these two cohorts are summarized in Table 1. A third cohort study, largely ignored by regulators, consisted of nearly 4,000 nonsmoking Seventh Day Adventists (SDA). In this study, similar in design to the Six Cities and ACS cohort studies, there did not appear to be an association between PM2,5 and mortality. Practically no mortality results were reported from this study, but there was extensive reporting on morbidity (5, 6) .
The purpose of this review is to assess whether the weight of the evidence supports a causal association between chronic exposure to fine particulate air pollution (PM25) and mortality. It is important to understand that the study of air pollution by observational studies is very difficult for a number of reasons, such as the complexity of the air mixture, the highly correlated nature of the pollutants, the relatively low exposure range and weak strength of association in the presence of stronger risk factors, the inability to completely control for confounders, and the lack of individual-level exposure data. These considerations suggest epidemiology may be at its limits (7) , and it may not be possible to correctly estimate the long-term risk of mortality from PM air pollution from epidemiology studies such as these.
Critique of Studies
The prospective cohort study (as used in the studies reviewed here) is a mixed design incorporating both individual-level data (such as cause of death, age, sex, smoking habits, body mass index, education) and group-level data on ambient air pollution concentrations. Variables that describe Conceptually, analysis of the data was conducted as if the two studies were experimental studies. In brief, differences in mortality (or survival) between groups (Six Cities, 50 metropolitan areas) were regressed against differences in annual PM2 5 while adjusting for differences in risk factors such as age, smoking, body mass index, and education. However, these are observational studies, not experimental studies. Cohort members were not randomly assigned in each city, and it is impossible to achieve between-city similarity in all-important risk factors. There is also not enough information available on each individual to make adequate statistical adjustments for differences in some risk factors. Thus, it may not be possible to reliably estimate the risk associated with between-city differences in PM2.5.
These PM2 5 cohort studies have generated the hypothesis that long-term exposure to annual PM2 5 concentrations at or above about 15 pg/--3 increases total and cardiopulmonary mortality. This hypothesis will be evaluated to determine if it is supported by the evidence, and whether the associations observed are likely to be causal.
This discussion of the scientific evidence will follow a simplified approach that is the logical progression from hypothesis to risk assessment: generate hypothesis -e test hypothesis and demonstrate cause-effect -> risk assessment.
Testing the hypothesis and establishing causality is a process of developing and assessing the body of data from individuallevel epidemiology and experimental studies. Each study must be evaluated regarding its suitability; for example, are individual-level data available for both exposure and response, and is there a lack of significant bias such as from confounding? The suitability of the individual studies will be integrated into the discussion of criteria propounded by Hill (8) for determining whether an association is causal or merely statistical.
The questions ofsuitability of the individual studies and assessment of a causal versus a statistical association are discussed below.
The section on risk assessment will conclude with a discussion of suggested requirements for epidemiological studies in estimating risk and in developing air quality standards.
Ecologic Study Design
As mentioned above, the prospective cohort study design incorporates individual-level data on cause of death, potential confounders (such as for age, sex, smoking habits, body mass index, education), and group-level (ecological) data on exposure (sulfate and PM,25 in the ACS cohort; total, inhalable and fine PM, sulfates, acidity, SO2, NO2, and 03 in the Six City cohort). The ecological study design is suitable for generating a hypothesis, but is generally not suitable for testing a hypothesis. Weaknesses in the study design and the need for independent confirmation using individual-level data are two reasons that caution in interpretation of ecologic study results is needed.
Weakness of Ecologic Study Design
Ecologic studies are generally considered inferior to individual-level studies because 1) they are subject to biases not present in individual-level studies; 2) the biases in ecologic studies are less well understood; and 3) the effect of biases on risk estimates is unpredictable in ecologic studies.
For example, Brenner et al. (9) showed that while exposure misclassification in individual-level studies often biases the risk estimate toward the null, exposure misclassification in ecological studies may produce extreme overestimates of risk [see also Greenland (10) ]. The "ecological fallacy" problem is one of falsely inferring that associations based on group data apply to individuals. That is, there is no way to know if the cohort members who died are also the same individuals who had high exposure to PM2 relative to those who did not die. The 1ack of any information on individual-level exposure has led some epidemiologists to conclude that one is "never justified in interpreting the results of ecological analyses in terms of the individuals who give rise to the data" (11) .
Temporality. The only causal criterion that must be met is that exposure must precede disease. For chronic disease with long latent periods, exposure must occur years or decades before disease. In these studies it is clear that exposure to ambient PM2.5 began at birth, so PM25 exposure clearly preceded disease. However, the estimates of exposure meet neither of the temporal criteria for latency or precedence. In the Six Cities study, deaths were tabulated for the periods between about 1979 and 1991, and PM2.5 data were collected beginning in the late 1970s. For the ACS cohort, vital status was assessed between 1982 and 1989, and fine particulate data were collected from 1979 to 1983. Thus, the exposure in the Six City study was concurrent with the responses. In the ACS cohort, there was inadequate latency because the exposure estimates were collected for no more than 3 years before the response for chronic diseases, which takes decades to develop. In both cases, the temporality criterion was not met.
One could argue that estimated exposure is a surrogate for lifetime exposure and therefore the temporality criterion is met. The following discussion suggests that ambient concentration as used in these studies is not an adequate surrogate for lifetime exposure. Exposure = Concentration x Time. In both the Six Cities and ACS cohorts, statistically significant associations were reported between mortality (total and cardiopulmonary) and mean ambient PM2.5 concentrations and over the concentration range equivalent to the difference between high and low polluted cities. Ideally, one would like to either measure or estimate longterm personal exposure to different air pollutants, i.e., collect individual-level data (12) . Measurement of personal exposure as a maximum involves wearing a personal monitor for many years. Estimation of individual-level exposure as a minimum might mean keeping a time-activity diary. What has been used in these studies as a surrogate for exposure is ambient mean concentrations of the geographical areas of the study subjects.
The use of mean ambient air concentration to estimate cumulative long-term exposures in the Six Cities and ACS cohorts is adequate only if several criteria are met.
One criterion is that ambient concentrations should be adequate surrogates for individual exposure. A single monitor for a city population does not provide information on personal exposure. In the sixth year of the Six Cities study, extensive indoor and outdoor monitoring for respirable size particles showed that indoor levels were significantly different from outdoor concentrations, and only a fraction of outdoor respirable PM was penetrating indoors. The differences were such that people "living in Volume 106, Number 9, September 1998 * Environmental Health Perspectives 536 exposed to higher levels of PM2.5 (13) .
In one of the Six Cities (Kingston/ Harriman), personal exposures were higher, had a greater variance than outdoor concentrations, and were uncorrelated with outdoor concentrations (14) .
Data from other cities also show that outdoor concentrations are poor surrogates for personal exposure. Ozkaynak et al. (15) (18) suggested that ambient PM is an appropriate surrogate, that it adequately characterizes personal exposure to ambient PM, that there is a clear "relationship between health outcomes and ambient PM concentrations," and, therefore, it is "reasonable to presume that reduction in ambient PM will help to protect the public from adverse health effects associated with personal exposure to ambient PM."
The EPA (18) argued that nonambient PM exposures vary independendy of ambient PM. Ambient PM is "expected to be a major portion of the ambient PM measured in a person's residential area" and is expected to be a major portion of personal exposure. Thus, nonambient PM "would probably not be a confounder in epidemiology studies" but could be an independent risk factor (18) . Because ambient PM is not correlated with nonambient PM, "epidemiological studies relating health outcomes to ambient PM would not provide any information about the health effects that may be caused by [nonambient] PM" (18) .
The only salient factors then, are that "there is a relationship between health outcomes and ambient PM," and there is a relationship between "ambient PM... and personal or population exposure to ambient PM" (18) .
There are two crucial assumptions in this argument: one is that ambient PM must constitute a major proportion of total PM exposure, and the second is that there is a constant proportionality between ambient and personal exposure to PM. While these assumptions may be met for nonsmokers living in residences without major indoor PM sources, they are not met for a large proportion of the rest of the population, in particular, the populations studied in the ACS and Six Cities cohorts. Table 3 ), ambient PM alone explained <1% of the variance in personal exposure, so this model had "no predictive power." Three additional predictive models (Levels 2 through 4) were analyzed. By adding more independent variables, the X2 values increased.
Indoor PM alone explained 47% of the variance of personal exposure overall. The predictive power of the fourth-level model varied with different subgroups in the population (i.e., 20% for employed subjects from nonsmoking households to 84% for nonemployed subjects from nonsmoking households). Spengler et al. (14) conduded that "misclassification and misassociation of exposures...are likely to result... [when] relying upon ambient community-based partide measurements."
Smokers are usually excluded in these assessments, and personal monitors do not measure directly inhaled mainstream tobacco smoke. Thus, nonsmokers comprise essentially the only group for which correlations of ambient/personal exposure have been assessed (19 (19) . The personal exposure of "dustytrade workers can also be several orders of magnitude greater than their exposure to indoor particles of ambient origin" (19) . The "inhalation of mainstream tobacco smoke will be a major additive exposure to PM for the smokers, which dwarfs the nonsmokers" personal exposure monitor PM exposure (19) . A major proportion of the U.S. population (e.g., smokers) has a total exposure to PM that is at least "one order of magnitude greater" than that of the nonsmokers (19 Geographic mobility. A third criterion is that account should be taken of both long-term and short-term geographic mobility. Long-term mobility refers to moves of residence or workplace to different cities. Short-term mobility refers to working at a location different from one's residence for each working day, and not working on weekends (12) . Geographic mobility has been addressed in the SDA cohort by interpolating monthly monitor data to the zip codes of the home and work locations (5, 6) .
A related criterion is that exposure estimates should include a significant portion of each individual's life span. This is not the case because of the limited time period when PM2.5 was sampled. The the Six Cities and ACS cohort studies and are compared to estimated group-level risks of ambient PM2'5 ( Fig. 1 and 2 
Confounding
The presence of a strong association and a biological gradient (exposure-response; E-R) are supportive of a causal association. A weak association is one in which the ratio of the frequency of mortality between high and low exposed groups is small in magnitude. A risk ratio of about 1.50 (i.e., 50% increase) is a weak association (29 Figure 3 graphically displays the potential effect of differences in FEV1 between cohort members in the Six Cities study. These are not precise estimates because the distribution of smokers in each city was not available, so it was necessary to assume the same distribution of smokers in each city (35 4 ).
While these results may not be conclusive for lifetime exposures because of short follow-up, relatively high dropout rate, small numbers, and variability in the data, the results suggest that PM25 in ambient air is unlikely to produce larger reductions in FEVI than those experienced by a light smoker exposed to about 6,000 pg/m3 tobacco smoke during the period of this study. These data also suggest that the differences in FEV1 between cities are not due to the small differences in ambient PM25. The lack of an apparent effect on FEV1 for light smokers is not coherent with an increase in mortality associated with much smaller exposures to PM25 air pollution.
Lifetime smoking data indicate a linear relationship between cumulative cigarette smoking measured as pack-years and irreversible loss of FEV1 and FVC in the Six Cities study (38) . The irreversible effect of cumulative pack-years on height-adjusted FEV1 is 7.4 ml/pack-year (-0.0004 ml/pgl m3 cigarette smoke), plus an additional reversible deficit of 123 ml for a total of 308 ml over 25 years for a pack/day smoker. For a 25 pack-year woman smoker, the estimated effect of cumulative smoking is 110 ml plus a reversible deficit of 107 These estimated losses in FEV1 from 25 years exposure to an annual average of 18.6 lpg/mi3 are much less than 1% of heightadjusted FEV1 and are too small to measure with reliability. These results are not coherent Volume 106, Number 9, September 1998 * Environmental Health Perspectiveswith the group-level estimates of mortality, as one would expect a larger effect on morbidity than mortality.
Cori and Mantel (39) suggested the threshold at which significantly increased risks of lung cancer, coronary heart disease, and respiratory disease mortality can be detected are about four to five cigarettes per day. This is an average exposure of about 3,300-4,200 pg/m3 for a 15-mg tar cigarette, or 150-210 times greater than the difference between high and low polluted cities. These individual-level estimates of risk from cigarette smoke are also not coherent with the group-level estimates ofrisk from PM2.5.
Arguing Coherence Using Time-Series Studies Pope et al. (4) state that time-series studies show that particulate air pollution is associated with declines in lung function, increased respiratory symptoms, respiratory hospitalizations, restricted activity due to respiratory illness, and increased mortality, especially respiratory and cardiovascular mortality. They suggest this "coherent cascade of cardiopulmonary health effects" enhances biological plausibility of the cohort mortality studies.
Use of time-series studies to support the coherence criterion is not appropriate. The questions addressed by time-series and prospective studies are different. Time-series studies attempt to answer whether individuals already sick with preexisting cardiorespiratory illness die because of episodes of short-term elevations in air pollution. Prospective cohort studies address the question of whether long-term exposure of primarily healthy individuals increases the risk of total and cardiopulmonary mortality. Dockery et al. (3) conduded that "because the daily time-series studies evaluated only the effect of short-term changes in pollution levels, whereas our study [Six Cities] evaluated associations with long-term exposure..., quantitative comparisons with these investigations are difficult to make."
Arguing Coherence Using Other Group-level Studies
It is a circular argument to use other ecological studies to test or validate either the consistency or coherence criteria. Ecologic studies are subject to similar biases and, in general, lack the rigor to test the hypothesis. If one does not accept this reasoning and uses ecological studies to assess the coherence criterion, the SDA cohort study and lung function data on children in the Six Cities study are the logical places to address the question of whether both mortality and morbidity are associated with PM in the same cohort. Seventh Day Adventist cohort. The SDA cohort contained no smokers (only nonsmokers and ex-smokers and included respiratory symptom data as well as mortality information over a 10-year period. The bulk of the study participants were in three areas in California (Los Angeles, San Diego, and San Francisco) (5, 6) . Exposure estimates included length of residence and more than one area monitor per person, and accounted for time spent at place of residence and job, as well as environmental tobacco smoke exposure. In a series of reports on the SDA cohort, a wide range of air pollutants besides PM were also assessed. In the SDA cohort, exposure is closer to individual-level exposure than in either the Six Cities or ACS cohorts.
In the SDA cohort, the RR for mortality associated with PM10 was not significant and was said to be around 1.0 (6). The RR for mortality associated with PM25 (based on visibility) was "close to, or less than, one" (6). The relative risk of developing new cases of airway obstructive disease (AOD), chronic bronchitis, and chronic productive cough were significantly associated with PM1O (RR = 1.17). The association was not significant for asthma or cough (5). The lack of an association for mortality is not consistent with the Six Cities and ACS cohorts. The presence of an association for morbidity, but not mortality, does not provide a coherent argument for mortality. However, morbidity is the more sensitive indicator of an effect, which is consistent with the coherence criterion (40) .
Even the association with symptoms is problematic. Logistic regression results were provided for new cases of AOD, chronic bronchitis, and asthma. However, reversal of these symptoms also occurred, as 34% to 51% of the symptoms went away between 1977 and 1987 ( (41, 42) . Both evaluated the same cohort of preadolescent school children, but PM25 measurements are available only for the later study (42) , which was analyzed as a cross-sectional study and used 12 months of PM2 5 data as the exposure variable (annual mean). Relative odds were calculated comparing the most polluted (Steubenville) and least polluted (Topeka) cities after adjustment for sex, age, maternal smoking, and use of a gas stove. There were no signiflcant associations of respiratory symptoms or lung function with PM2.5 (except hay fever, which showed a negative relationship). RR estimates were elevated about twofold for bronchitis, chronic cough, and chest illness. The widest 95% confidence interval (CI) and highest RR was for chronic cough (RR = 2.3; CI = 0.4, 13.2). There was "no evidence for an effect" ofpollution exposure on any measure of lung function, even in children with persistent wheeze, despite use of potentially more sensitive measures of small airways response than FEV1 and FVC (42) . Children generally spend more time outdoors than adults and have a greater specific ventilation (liters per kilogram body mass).
The adjustments for potential confounders may not be adequate. For example, the RRs were not adjusted for season, although the RR for bronchitis associated with PM15 was reduced from 2.52 to 1.97 when such an adjustment was made. Also, Dockery et al. (42) suggested that effects of acute exposure occurring before examination may have masked any chronic effects. The cross-sectional study design may not provide suffilcient power to detect significant differences. 
Summary
The coherence and consistency criteria were not met using either individual-level or ecological-level data. The individuallevel data suggested a possible threshold effect at or below about five cigarettes per day on lung function (from Six Cities data), as well as coronary heart disease and respiratory disease mortality (39) . The PM2.5 concentration difference between high and low polluted cities was more than two orders of magnitude below the threshold, and any effect of the long-term exposure to these concentrations on lung function was undetectable.
Using group-level data from the SDA cohort, the coherence criterion was not met because 1) there was no PM2 5/mortality association; 2) the PM10/symptom associations showed an implausibly high strength of association; and 3) the long-term biological significance of the symptoms was undear, given the high frequency of symptom reversal and the lack of any analysis showing no association between PM25 and symptom reversal.
Biological Plausibility
Are the results biologically plausible and do they agree with current understanding of how organisms respond to low concentrations of PM? Plausibility is not a required criterion to demonstrate causality. However, if ecologic study designs are being used to both generate and test the hypothesis as well as for risk assessment, then biological plausibility takes on added importance. An increased level of proof is required because ecologic studies are subject to the ecologic fallacy, and the smoking analogy indicates large overestimates of risk.
There appears to be general agreement that no plausible mechanism is presently available to explain the associations between chronic exposure to PM2.5 air pollution and increased mortality. Pope et al. (4) indicated that additional research is needed to "help a toxicologic framework for interpreting these [ACS] findings."
The hypothesis predicts that long-term exposure to fine particulate should increase mortality. There are experimental data of lifetime exposure of animals to fine particulate matter showing no increased mortality even though exposures are so high as to produce lung overload (submicron diesel particulate was used as the fine particulate). Exposure was adjusted to reflect average 168-hr weekly exposures, which is analogous to an annual average. Despite average concentrations of diesel exhaust particulate up to 100 times higher than the most polluted city in the Six Cities study, mortality was not increased (43) 43 pg/m3 (45) . Thus, impaired dearance and increased lung burden due to PM2 5-induced overload are unlikely to occur.
Pritchard (46) suggested that overload also occurs in humans when human exposures are such that lung burdens approach those seen in animal experiments. It Table  5 , along with comments pertaining to whether the PM2.5 studies meet the suggested requirements. The EPA (18) endorses the use of these criteria in contributing to the weight-of-evidence determination of a human health hazard.
The EPA position on the need for individual-level exposure data is somewhat ambiguous. The EPA only has regulatory authority over outdoor air and argues that variations in ambient PM are reflected in variations in personal PM exposure and that ambient PM is "hypothesized to create the health effects" (18) . Therefore, reduction in ambient PM will "help to protect the public from adverse health outcomes associated with personal exposure to ambient PM" (18) . Thus, there is no need for E-R trends based on individual-level exposures.
The opposing side to this argument is discussed primarily in the section on ecologic study design. The contribution of ambient PM to personal PM is small for a majority of the population, and the health effects are probably too small to measure in individuals or populations. The EPA has also presented statements suggesting that quantification of individual-level exposure may be necessary. Personal exposure is said to be "important in itself, because the body may react differently to ambient and nonambient particles" (1p). Personal PM may act as a confounder in ecological studies, and personal PM is a "critical parameter... [when] health outcomes are being tracked individually" (19) .
As shown in Table 5 , none of the HertzPicciotto criteria for quantification of risk and setting air quality standards using epidemiology studies are met.
The first and fifth criteria are the strength of association and biological gradient causal criteria outlined by Hill (8) . These were discussed above where it was suggested that the group-level strength of association was exaggerated and the biological gradient (E-R) could not be determined because of uncontrolled confounding and inadequate estimate of exposure. The third criterion is not met because it is likely that various factors may be confounding the associations reported in the Six Cities and ACS studies. Physical inactivity and FEV1 were identified as two The PM2 RRs for total and cardiopulmonary mortality are orders of magnitude too high when tested using the tobacco analogy. That is, group-level data from the Six Cities and ACS cohorts suggest that PM25 is 35-1,000 times more toxic than smoke from a low-tar cigarette on a weight/volume basis. This is a conservative estimate, as most smokers smoke cigarettes with more tar, and lowtar cigarettes have been available only recently in the life span ofstudy subjects.
Even if PM2.5 were as toxic as cigarette smoke PM, the prospective study design could cohort shows that the effect of ambient PM2,5 than death. Thus, because the small differences Risk estimates from these studies are exaggeratis too small to have an independent measurable in PM25 between high and low polluted cities ed, and these investigations do not meet the effect on FEV1. Thus, the observed association do not produce measurable differences in lung criteria for a quantitative risk assessment. of PM2 5 and mortality may be in large part function, it is unlikely that they would produce
The weight ofthe evidence is not sufficient explained by unadjusted confounding. measurable differences in mortality.
to support the hypothesis of a causal associaThe biases inherent in group-level esti-
The plausibility criterion is not met tion (Table 6 ). mates of exposure (exposure misclassification because rodents exposed for a lifetime to high bias) and the unadjusted confounding pro-concentrations of a mixture containing fine .The comparison for the two symptom categories are summarized in Tabl.e A2-1.
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